Skip to main content

Table 1 Baseline demographic and clinical parameters of the study population

From: Evaluation of effect of cooled haemodialysis on cognition in patients with end-stage kidney disease (ECHECKED) feasibility randomised controlled trial results

 

Standard

Low

Total

N

20

23

43

Age (years)

67 (55–76)

68 (59–77)

68 (59–77)

Gender

   

Male

13 (65)

16 (70)

29 (67)

Female

7 (35)

7 (30)

14 (33)

Ethnicity

   

Caucasian

14 (70)

13 (56)

27 (63)

Asian

1 (5)

5 (22)

6 (14)

African

5 (25)

5 (22)

10 (23)

Time on Dialysis (months)

60 (37–99)

56 (37–118)

58 (37–114)

MOCA

21.9 ± 4.6

20.7 ± 6.2

21.2 ± 5.5

HADS Depression

6.5 ± 3.5

4.8 ± 2.4

5.6 ± 3.0

HADS Anxiety

3.0 (1.0–8.0)

3.0 (1.0–4.0)

3.0 (1.0–5.5)

AQOL

48.1 ± 9.6

45.6 ± 8.2

47.7 ± 8.8

PreHD SBP (mmHg)

147.2 ± 24.1

140.0 ± 20.4

143.3 ± 22.2

preHD DBP (mmHg)

72.9 ± 13.4

65.9 ± 10.3

69.0 ± 12.2

Post HD SBP (mmHg)

130.9 ± 21.0

132.6 ± 14.3

131.9 ± 17.4

Post HD DBP (mmHg)

62.0 ± 12.5

63.9 ± 10.5

63.0 ± 11.3

Kt/V

1.33 ± 0.16

1.36 ± 0.26

1.34 ± 0.22

Hb (g/dL)

11.5 ± 0.94

11.0 ± 1.17

11.2 ± 1.09

Alb (g/L)

32.8 ± 3.9

31.4 ± 4.2

32.1 ± 4.1

C.Ca (mmol/L)

2.40 ± 0.15

2.40 ± 0.12

2.40 ± 0.13

Phosphate (mmol/L)

1.60 (1.41–2.04)

1.30 (1.18–1.70)

1.50 (1.19–1.84)

PTH (pmol/L)

48.2 ± 28.0

45.5 ± 23.9

46.7 ± 25.6

  1. Data presented as either Mean ± SD; Median (IQR); N (%)